-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Agile Therapeutics Inc quarterly/annual Cost of Revenue history and growth rate from Q1 2021 to Q2 2024.
- Agile Therapeutics Inc Cost of Revenue for the quarter ending June 30, 2024 was $1.5M, a 35.2% decline year-over-year.
- Agile Therapeutics Inc Cost of Revenue for the twelve months ending June 30, 2024 was $7.84M, a 6.17% increase year-over-year.
- Agile Therapeutics Inc annual Cost of Revenue for 2023 was $8.98M, a 31.3% increase from 2022.
- Agile Therapeutics Inc annual Cost of Revenue for 2022 was $6.84M, a 36.2% decline from 2021.
- Agile Therapeutics Inc annual Cost of Revenue for 2021 was $10.7M, a 3701% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)